Skip to content

This content is in French.

The 62nd American Society of Hematology Annual Meeting and Exposition ASH 2020

5 Décembre 2020 · 4 joursSan Diego, United StatesHematologyEnglish
The 62nd American Society of Hematology Annual Meeting and Exposition ASH 2020
San Diego

About this congress

With more than 17,000 members from nearly 100 countries, the American Society of Hematology (ASH) is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.

Videos from this congress

Monica Bocchia · Peripheral blood CD26+ leukaemia stem cell monitoring in CML during TKI treatment
Play the video · Monica Bocchia · Peripheral blood CD26+ leukaemia stem cell monitoring in CML during TKI treatmentFree registration required to play

Monica Bocchia · 00:08:45

Adam Cohen · Clinical activity and safety of cevostamab in relapsed/refractory multiple myelomavvvv
Play the video · Adam Cohen · Clinical activity and safety of cevostamab in relapsed/refractory multiple myelomavvvvFree registration required to play

Adam Cohen · 00:07:35

Simon Harrison · Novel bispecific T-cell engager molecule shows promise in r/r multiple myeloma
Play the video · Simon Harrison · Novel bispecific T-cell engager molecule shows promise in r/r multiple myelomaFree registration required to play

Simon Harrison · 00:05:25

Francesca Gay · Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the random
Play the video · Francesca Gay · Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomFree registration required to play

Francesca Gay · 00:03:06

Patricio Duarte · Latest advice on the management of multiple myeloma patients
Play the video · Patricio Duarte · Latest advice on the management of multiple myeloma patientsFree registration required to play

Patricio Duarte · 00:08:24

Robert Rifkin · ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma
Play the video · Robert Rifkin · ASH 2020: Immunotherapy in relapsed/refractory multiple myelomaFree registration required to play

Robert Rifkin · 00:28:45

Marivi Mateos · ASH 2020: Targeted therapies in r/r multiple myeloma
Play the video · Marivi Mateos · ASH 2020: Targeted therapies in r/r multiple myelomaFree registration required to play

Marivi Mateos · 00:21:26

E2E Chen Kumar-ecancer Web
Play the video · E2E Chen Kumar-ecancer WebFree registration required to play

00:12:45

Elena Zamagni · FORTE Trial: Impact of imaging FDG-PET/CT minimal residual disease assessment on multiple myeloma
Play the video · Elena Zamagni · FORTE Trial: Impact of imaging FDG-PET/CT minimal residual disease assessment on multiple myelomaFree registration required to play

Elena Zamagni · 00:03:52

Mark Hertzberg · B-HOLISTIC study and the importance of r/r Hodgkin lymphoma real world evidence data
Play the video · Mark Hertzberg · B-HOLISTIC study and the importance of r/r Hodgkin lymphoma real world evidence dataFree registration required to play

Mark Hertzberg · 00:15:40

Ola Landgren · Evaluation of MRD negativity in patients with relapsed or refractory multiple myeloma treated
Play the video · Ola Landgren · Evaluation of MRD negativity in patients with relapsed or refractory multiple myeloma treatedFree registration required to play

Ola Landgren · 00:06:42

David Teachey · Cranial radiation mostly eliminated in children with T-ALL and bortezomib potentially improves
Play the video · David Teachey · Cranial radiation mostly eliminated in children with T-ALL and bortezomib potentially improvesFree registration required to play

David Teachey · 00:04:51